The US industrial hemp market faces significant policy challenges, risking its economic potential. Learn how current ...

Explore the Trump administration's federal medical cannabis reclassification, moving it from a highly controlled category and ...

A campaigner advocates for Crown Dependencies to implement cannabis policy pilot schemes, focusing on public health data and ...

A recent advisory from Maine's Office of Cannabis Policy highlights unsafe levels of mold and pesticides in medical cannabis ...

Medical cannabis program enrollment is expected to surge after Schedule III rescheduling. Learn how tax relief, insurance ...

The West Virginia Supreme Court is reviewing if medical cannabis odor alone provides probable cause for home searches, ...

HempToday's Kehrt Reyher discusses industrial hemp policy, CBD regulation, and market development. Insights cover legislative ...

Explore how U.S. Congressional actions are impacting industrial hemp businesses and the proposed marijuana rescheduling, ...

Explore the US Justice Department's reclassification of medical cannabis to Schedule III, impacting tax breaks for businesses ...

A Travis County district judge has extended a temporary injunction, allowing Texas shops to continue selling smokable hemp ...

The DEA clarifies hexahydrocannabinol (HHC) is a federally illegal Schedule I substance, assigning it a new drug code. This ...

Explore how federal cannabis rescheduling could activate existing South Carolina laws, potentially granting patients medical ...